Market Rasen, United Kingdom

William Mitchell

This inventor holds 10 USPTO granted patents and 3 EPO patents. Top assignee: Chdi Foundation, Inc.. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Mitchell. Retrieved from https://idiyas.com/inventor/william-mitchell-7ew11l7x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Lincolnshire, GB (2016 - 2018)
  • Market Rasen, GB (2017 - 2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations by William Mitchell: Pioneering Kynurenine-3-Monooxygenase Inhibitors

Introduction

William Mitchell, an accomplished inventor based in Market Rasen, Great Britain, has made significant contributions to the pharmaceutical field with his innovations. With a total of 10 patents, his work primarily focuses on developing new compounds that aim to treat neurodegenerative diseases.

Latest Patents

One of Mitchell's latest patents centers on Kynurenine-3-monooxygenase (KMO) inhibitors, which include pharmaceutical compositions and methods of use. This patent outlines the provision of various compounds and their pharmaceutically acceptable salts or prodrugs, designed to provide effective treatment for patients suffering from diseases responsive to KMO activity inhibition. Notably, these diseases encompass neurodegenerative disorders such as Huntington's disease. The patent describes methods for administering these compounds, either as single agents or in combination with other therapeutic entities, as well as novel methods for screening compounds capable of inhibiting KMO activity.

Career Highlights

Mitchell's career is defined by his relentless pursuit of innovation in pharmaceutical sciences, and his significant patent portfolio stands testament to his expertise and contributions. His research efforts have the potential to address pressing medical needs, particularly in treating neurodegenerative conditions that significantly impact patients' lives.

Collaborations

William Mitchell collaborates with esteemed colleagues such as Michael Edward Prime and Celia Dominguez. Together, they work at the CHDI Foundation, Inc., striving to bridge the gap between scientific research and practical therapeutic solutions.

Conclusion

With a focus on developing KMO inhibitors and other pharmaceutical innovations, William Mitchell is carving out a respected position within the field of drug development. His patents not only showcase his inventiveness but also highlight the collaborative efforts essential in the progress of medical research and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…